Arcturus Therapeutics Holdings Inc (ARCT)
27.07
-0.47
(-1.71%)
USD |
NASDAQ |
May 08, 11:51
Arcturus Therapeutics Holdings 1 Year Total Returns (Daily): 1.62% for May 7, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 07, 2024 | 1.62% |
May 06, 2024 | 0.81% |
May 03, 2024 | 2.98% |
May 02, 2024 | 4.82% |
May 01, 2024 | 6.85% |
April 30, 2024 | -3.94% |
April 29, 2024 | 0.04% |
April 26, 2024 | -0.38% |
April 25, 2024 | -6.80% |
April 24, 2024 | -5.33% |
April 23, 2024 | 0.90% |
April 22, 2024 | -2.24% |
April 19, 2024 | -7.11% |
April 18, 2024 | -5.60% |
April 17, 2024 | -0.04% |
April 16, 2024 | 9.29% |
April 15, 2024 | 6.31% |
April 12, 2024 | 15.92% |
April 11, 2024 | 20.65% |
April 10, 2024 | 27.67% |
April 09, 2024 | 21.21% |
April 08, 2024 | 18.42% |
April 05, 2024 | 21.98% |
April 04, 2024 | 13.21% |
April 03, 2024 | 27.39% |
Date | Value |
---|---|
April 02, 2024 | 34.42% |
April 01, 2024 | 38.01% |
March 28, 2024 | 117.9% |
March 27, 2024 | 107.3% |
March 26, 2024 | 104.6% |
March 25, 2024 | 121.6% |
March 22, 2024 | 130.3% |
March 21, 2024 | 115.1% |
March 20, 2024 | 116.0% |
March 19, 2024 | 119.4% |
March 18, 2024 | 115.3% |
March 15, 2024 | 127.8% |
March 14, 2024 | 130.2% |
March 13, 2024 | 144.4% |
March 12, 2024 | 162.5% |
March 11, 2024 | 157.1% |
March 08, 2024 | 125.7% |
March 07, 2024 | 132.3% |
March 06, 2024 | 138.5% |
March 05, 2024 | 127.9% |
March 04, 2024 | 128.5% |
March 01, 2024 | 143.7% |
February 29, 2024 | 138.5% |
February 28, 2024 | 147.3% |
February 27, 2024 | 167.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-75.03%
Minimum
Sep 23 2022
1.05K%
Maximum
Dec 07 2020
97.82%
Average
34.72%
Median
Dec 07 2023
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -13.18% |
Perspective Therapeutics Inc | 179.2% |
Protalix BioTherapeutics Inc | -65.14% |
Electromed Inc | 55.64% |
Armata Pharmaceuticals Inc | 93.24% |